Network Pharmacology Analysis of Bioactive Components and Mechanisms of Action of Qi Wei Wan Formula for Treating Non-Small Cell Lung Carcinoma
Open Access
- 6 October 2022
- journal article
- research article
- Published by SAGE Publications in Natural Product Communications
- Vol. 17 (10)
Abstract
Astragali Radix (AR) and Schisandrae chinensis Fructus (SCF) have been used individually and in traditional Chinese medicine (TCM) formulas for treating non-small cell lung carcinoma (NSCLC). Qi Wei Wan (QWW), a 2-herb TCM formula composed of AR and SCF, is used to treat blood deficiency, fatigue, and metabolic abnormalities. We speculate that QWW may be more effective in treating NSCLC than AR or SCF alone. We identified 28 bioactive compounds in QWW and 322 targets of these compounds from databases. Network pharmacology analysis was used to identify 248 putative NSCLC-related gene targets of the bioactive compounds in QWW. Common target genes were analyzed to build protein–protein interaction networks. Implicated biological functions and pathways (p53, PI3K-Akt, etc) were identified by Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. Molecular docking of core target proteins with the key active compounds was also performed. This study identified the potential gene targets and mechanisms involved in the anti-NSCLC effects of QWW.Keywords
Funding Information
- the Science and Technology Innovation Bureau of Guangzhou Development District (CY2019-005)
- the Guangzhou Innovation and Entrepreneurship Leading Team Project (202009020005)
This publication has 49 references indexed in Scilit:
- TP53 Mutations in Nonsmall Cell Lung CancerBioMed Research International, 2011
- Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer riskCarcinogenesis, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Network pharmacology: the next paradigm in drug discoveryNature Chemical Biology, 2008
- Drugging the Cancer Chaperone HSP90Annals of the New York Academy of Sciences, 2007
- Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft modelBMC Cancer, 2007
- Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell LinesThe American Journal of Pathology, 2007
- Kaempferol‐induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK‐MAPKJournal of Cellular Physiology, 2003
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Gomisin A, a lignan component of Schizandora fruits, inhibits development of preneoplastic lesions in rat liver by 3′-methyl-4-dimethylamino-azobenzeneCancer Letters, 1994